coronavirus January 5, 2024 8:02 am

Study examines effectiveness of main COVID treatment Paxlovid

A new study by researchers at UCSF shows that Paxlovid does not reduce the risk of long COVID, but infectious disease specialist Dr. Peter Chin-Hong said the drug is still effective at preventing severe disease in vulnerable people.

US & World Videos

4:02

Updated COVID vaccines coming
3:17

Slight summer uptick of COVID cases in California
3:57

Interview: Doctor's perspective on COVID 4 years after shutdown started
2:09

CDC updates COVID isolation guidelines
3:39

California sees drastic drop in COVID-related deaths
Exit mobile version